All of this with a lower capex than the scoping study. We are trading at 1/10th of the NPV! Has anyone seen a PFS with better economics than Abra this year? My only fear at this stage is one of the big guys will take us out under 40c.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025